Symbols

PACS

PACS·NYSE

--(--)

PACS fundamentals

PACS Q4 2025 Earnings

PACS (PACS) released its earnings on Feb 26, 2026: revenue was 1.37B (YoY +31.32%), missed estimates; EPS was 0.461 (YoY +17.87%), missed estimates.

Revenue / YoY

1.37B

+31.32%

EPS / YoY

0.461

+17.87%

Report date

Feb 26, 2026

PACS Earnings Call Summary for Q4,2025

Record 2025 Performance: $5.29B revenue (+29% YoY), 207 facilities (73.4%) with 4-5 star CMS ratings, and 0.3x net leverage.
2026 Growth Outlook: $5.65-5.75B revenue (+8%), $555-575M EBITDA (+12%), targeting 8-10 acquisitions/year.
Clinical Excellence: 5-star CMS rating improvement case study, 12%+ skilled mix growth in mature facilities.
Strategic Expansion: 8 ground-up projects, 102 owned facilities, and selective real estate ownership to reduce lease costs.

Earnings

EPS

Revenue

Revenue & Expenses

PACS has released its 2025 Q4 earnings report, with revenue of 1.36B, reflecting a YoY change of 12.43%, and net profit of 59.78M, showing a YoY change of 65.19%. The Sankey diagram below clearly presents PACS's revenue sources and cost distribution.

Key Indicators

PACS (PACS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

PACS (PACS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

PACS (PACS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

PACS (PACS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown